Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy [NA]

View source ↗

Summary

This clinical trial update describes a study for advanced leiomyosarcoma using human organoid-guided personalized efficacy. Enrolment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Advanced Leiomyosarcoma | NA | Status: ENROLLING_BY_INVITATION